BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33602785)

  • 41. Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus.
    Yun HY; Kim MW; Lee HS; Kim W; Shin JH; Kim H; Shin HC; Park H; Oh BH; Kim WK; Bae KH; Lee SC; Lee EW; Ku B; Kim SJ
    PLoS Biol; 2019 Jul; 17(7):e3000367. PubMed ID: 31323018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma.
    Lin Y; Chahal HS; Wu W; Cho HG; Ransohoff KJ; Song F; Tang JY; Sarin KY; Han J
    Int J Cancer; 2017 Sep; 141(5):952-957. PubMed ID: 28510302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Population-Based Penetrance of Deleterious Clinical Variants.
    Forrest IS; Chaudhary K; Vy HMT; Petrazzini BO; Bafna S; Jordan DM; Rocheleau G; Loos RJF; Nadkarni GN; Cho JH; Do R
    JAMA; 2022 Jan; 327(4):350-359. PubMed ID: 35076666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical implications of germline mutations in breast cancer genes: RECQL.
    Bowden AR; Tischkowitz M
    Breast Cancer Res Treat; 2019 Apr; 174(3):553-560. PubMed ID: 30610487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
    Hatterschide J; Brantly AC; Grace M; Munger K; White EA
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.
    Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrating pathway analysis and genetics of gene expression for genome-wide association study of basal cell carcinoma.
    Zhang M; Liang L; Morar N; Dixon AL; Lathrop GM; Ding J; Moffatt MF; Cookson WO; Kraft P; Qureshi AA; Han J
    Hum Genet; 2012 Apr; 131(4):615-23. PubMed ID: 22006220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
    Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
    Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.
    Graffeo R; Rana HQ; Conforti F; Bonanni B; Cardoso MJ; Paluch-Shimon S; Pagani O; Goldhirsch A; Partridge AH; Lambertini M; Garber JE
    Breast; 2022 Oct; 65():32-40. PubMed ID: 35772246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families.
    Fidalgo F; Torrezan GT; Sá BCS; Barros BDF; Moredo LF; Valieris R; de Souza SJ; Duprat JP; Krepischi ACV; Carraro DM
    PLoS One; 2022; 17(1):e0262419. PubMed ID: 35085295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas.
    Liboutet M; Portela M; Delestaing G; Vilmer C; Dupin N; Gorin I; Saiag P; Lebbé C; Kerob D; Dubertret L; Grandchamp B; Basset-Seguin N; Soufir N
    J Invest Dermatol; 2006 Jul; 126(7):1510-7. PubMed ID: 16645598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A genome-wide analysis of gene-caffeine consumption interaction on basal cell carcinoma.
    Li X; Cornelis MC; Liang L; Song F; De Vivo I; Giovannucci E; Tang JY; Han J
    Carcinogenesis; 2016 Dec; 37(12):1138-1143. PubMed ID: 27797824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rare germline variants in known melanoma susceptibility genes in familial melanoma.
    Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR
    Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.
    Nan H; Kraft P; Hunter DJ; Han J
    Int J Cancer; 2009 Aug; 125(4):909-17. PubMed ID: 19384953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathway analysis for genome-wide association study of basal cell carcinoma of the skin.
    Zhang M; Liang L; Xu M; Qureshi AA; Han J
    PLoS One; 2011; 6(7):e22760. PubMed ID: 21829505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Environment, phenotype and genetics: risk factors associated with BCC of the skin.
    Hoban PR; Ramachandran S; Strange RC
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):570-9. PubMed ID: 12382525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction.
    Nelson HH; Kelsey KT; Mott LA; Karagas MR
    Cancer Res; 2002 Jan; 62(1):152-5. PubMed ID: 11782372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case-control study of MC1R variants in Greek patients with basal cell carcinoma: increased risk independently of pigmentary characteristics.
    Dessinioti C; Sypsa V; Kypreou K; Dimisianos G; Kodela E; Nikolaou V; Antoniou C; Stratigos AJ
    Exp Dermatol; 2015 Jun; 24(6):476-8. PubMed ID: 25809071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient identification of trait-associated loss-of-function variants in the UK Biobank cohort by exome-sequencing based genotype imputation.
    Yu WY; Yan SS; Zhang SH; Ni JJ; Bin-Li ; Pei YF; Zhang L
    Genet Epidemiol; 2023 Mar; 47(2):121-134. PubMed ID: 36490288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential association of single nucleotide polymorphisms in pigmentation genes with the development of basal cell carcinoma.
    Kosiniak-Kamysz A; Pośpiech E; Wojas-Pelc A; Marcińska M; Branicki W
    J Dermatol; 2012 Aug; 39(8):693-8. PubMed ID: 22512251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.